What To Expect When Changing Immunoglobulin (IG) Brands

Introduction

Immunoglobulin (IG) therapy is used to treat a variety of conditions, including primary immunodeficiency diseases and certain autoimmune disorders. There are several FDA-approved immunoglobulin products available, and although they all work by providing antibodies or modifying the immune response, they are not considered directly interchangeable. Differences in formulation, concentration, and administration may affect how well a particular product is tolerated. While many patients remain on the same brand for years, there are situations in which switching immunoglobulin products may be necessary.

What Is Immunoglobulin?

Immunoglobulin (IG) therapy contains antibodies collected from the plasma of thousands of healthy donors. It helps prevent infections in people who cannot produce enough antibodies on their own and can also help regulate an overactive immune system in certain autoimmune diseases.

Naturally occurring antibodies are divided into five classes (IgA, IgD, IgE, IgG, and IgM), each serving a different role in the immune system. Most immunoglobulin replacement and immunomodulatory therapies primarily contain immunoglobulin G (IgG), the antibody responsible for protecting against many bacterial and viral infections.

Several FDA-approved immunoglobulin products are available, including Hizentra, Privigen, Gammagard, Gammaked, Octagram, and others. Some are administered intravenously (IVIG), while others are given subcutaneously (SCIG). Although these products are similarly effective for approved indications, they differ in concentration, stabilizing ingredients, infusion schedules, and other characteristics that may affect individual patients.

Reasons You May Be Asked To Switch IG brands

Your healthcare provider may recommend switching immunoglobulin products if your current therapy is unavailable, causes unacceptable side effects, or another product is better suited to your medical needs or insurance coverage.

• The manufacturer may no longer be able to provide the medication due to supply issues.
• The manufacturer may have replaced the product with an alternate one.
• Your current IG brand causes serious adverse reactions.
• Your insurance plan changes its preferred immunoglobulin product or formulary coverage.

If you encounter one of the situations mentioned above, your physician may ask you to change IG brands. 

Although all FDA-approved immunoglobulin products meet strict standards for safety and effectiveness, they are not identical. Products may differ in IgA content, stabilizing ingredients (such as glycine or proline), concentration, sodium or sugar content, infusion rates, and manufacturing processes. These differences may influence how well an individual tolerates a specific product.

What To Expect When Changing IG Brands

1. Changes in Side Effects Experienced

Some patients notice changes in side effects after switching immunoglobulin products. Common reactions include headache, fatigue, chills, nausea, flushing, or infusion-site reactions. For some individuals, these side effects improve after switching products, while others may experience new or different reactions. Your healthcare provider may recommend adjusting the infusion rate or using premedications to reduce side effects during the transition. 

For example, studies have shown that some patients who experienced significant side effects with intravenous immunoglobulin (IVIG) reported fewer systemic side effects after switching to subcutaneous immunoglobulin (SCIG).

2. Changes in the Frequency of Administration

If you switch from IVIG to SCIG, you will be required to administer the medication more frequently. Conversely, if you switch from SCIG to IVIG, you will need to administer the medication less often. IVIG is typically given every 3 to 4 weeks, while SCIG is usually administered weekly or more frequently in smaller doses. Because IVIG delivers a larger dose at one time, some patients experience more infusion-related side effects than with SCIG. 

3. Significant Lifestyle Adjustments

Depending on the type of immunoglobulin prescribed, switching products may change where and how often you receive treatment. It may also affect the amount of time spent receiving infusions and the level of independence you have in managing therapy.  For example, patients switching from SCIG products (which can be self-administered in the comfort of their homes) to IVIG products may have to routinely report and spend more time at hospitals or infusion centers, where a nursing team can monitor for any adverse reactions.

4. Your Healthcare Team Will Monitor the Transition 

Most patients switch immunoglobulin products without major problems when the change is supervised by their healthcare provider. Your physician may monitor you more closely during your first few infusions to watch for side effects and ensure the new product is working as expected. Blood tests or adjustments to your infusion schedule may occasionally be needed.

Conclusion

Switching immunoglobulin products can feel overwhelming, but many patients transition successfully under the guidance of their healthcare provider. Although different immunoglobulin brands are similarly effective, they vary in formulation, administration schedule, and tolerability. If your provider recommends changing products, discuss what to expect, report any new side effects promptly, and never switch brands without medical supervision.

Frequently Asked Questions

Are all immunoglobulin brands equally effective?

Yes. All FDA-approved immunoglobulin products have been shown to be safe and effective for their approved uses. However, individual patients may tolerate one product better than another because brands differ in their formulation, concentration, stabilizing ingredients, and method of administration. Your healthcare provider can help determine which product is the best fit for your condition.

Can I switch from IVIG to SCIG?

Yes. Many patients successfully transition from IVIG to SCIG or vice versa. Your healthcare provider will determine the appropriate dose and schedule based on your medical condition, treatment goals, and previous response to therapy.